Synergistic Antitumor Activities of Sepantronium Bromide (YM155), a Survivin Suppressant, in Combination with Microtubule-Targeting Agents in Triple-Negative Breast Cancer Cells
Naoki Kaneko(University of California, Los Angeles), Masamichi Mori(Astellas Pharma (Japan))
Cited by 21
Related Papers
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
|Investigational New Drugs|2017|254
Novel plasma biomarker surrogating cerebral amyloid deposition
|Proceedings of the Japan Academy Series B|2014|140
Casein Kinase 1 Suppresses Activation of REST in Insulted Hippocampal Neurons and Halts Ischemia-Induced Neuronal Death
|Journal of Neuroscience|2014|61
Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome
|Scientific Reports|2022|36
Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome
|Research Square|2022|1